Main
>
INFLUENZA VIRUS
>
Infection. Vaccines. Additives
>
Recombinant NeurAminidase
>
Co.: USA. P (Dev./Patents)
>
Status: Completed Phase II(b)
Status: Completed Phase II(b)'s products
This section has no products